Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-13-010949
Filing Date
2013-12-03
Accepted
2013-12-03 06:00:47
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 a2217591z424b4.htm 424B4 1950767
2 G1039421.JPG g1039421.jpg GRAPHIC 16235
3 G160188.JPG g160188.jpg GRAPHIC 89657
4 G939147.JPG g939147.jpg GRAPHIC 101460
5 G288219.JPG g288219.jpg GRAPHIC 116655
6 G764396.JPG g764396.jpg GRAPHIC 27018
7 G82287.JPG g82287.jpg GRAPHIC 51623
8 G726673.JPG g726673.jpg GRAPHIC 49392
9 G326707.JPG g326707.jpg GRAPHIC 19538
10 G493520.JPG g493520.jpg GRAPHIC 41586
11 G397319.JPG g397319.jpg GRAPHIC 47164
12 G570984.JPG g570984.jpg GRAPHIC 32520
13 G386720.JPG g386720.jpg GRAPHIC 31010
  Complete submission text file 0001047469-13-010949.txt   2812926
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-191689 | Film No.: 131253112
SIC: 2834 Pharmaceutical Preparations